| name | nk-cell-therapy-agent |
| description | AI-powered NK cell therapy design for cancer immunotherapy including CAR-NK engineering, memory-like NK generation, and KIR/HLA matching optimization. |
NK Cell Therapy Agent
The NK Cell Therapy Agent provides AI-driven design and optimization of natural killer cell therapies for cancer treatment. It covers CAR-NK engineering, cytokine-induced memory-like (CIML) NK generation, KIR/HLA matching, and NK cell expansion optimization.
When to Use This Skill
- When designing CAR-NK constructs for tumor targeting.
- To optimize KIR/HLA mismatch for allogeneic NK therapy.
- For generating memory-like NK cells with enhanced persistence.
- When predicting NK cell activation against specific tumor types.
- To analyze NK cell receptor repertoires and function.
Core Capabilities
-
CAR-NK Design: Design chimeric antigen receptors optimized for NK cell biology (NK-specific signaling domains).
-
KIR/HLA Matching: Predict KIR-HLA interactions for donor selection in allogeneic therapy.
-
Memory-Like NK Generation: Optimize CIML protocol with IL-12/15/18 cytokine preactivation.
-
Expansion Optimization: ML models for feeder-free NK expansion conditions.
-
Tumor Target Prediction: Match NK receptor profiles to tumor ligand expression.
-
Persistence Enhancement: Engineering strategies for improved in vivo survival.
NK Cell Advantages Over T Cells
| Feature | NK Cells | T Cells |
|---|
| MHC requirement | No |